UPDATE 2- U.S. spurns AstraZeneca's nasal spray flu vaccine as ineffective

LONDON/CHICAGO, June 23 (Reuters) - U.S. health officials

have advised doctors not to use AstraZeneca's FluMist in

the upcoming flu season based on three years of U.S. data

showing that the nasal spray vaccine is not effective at

preventing influenza.

Read more